Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation
Biophysical Journal · 2023
DOI: 10.1016/j.bpj.2023.05.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biophysical Journal, 2023. Verfasst von Eli H Worth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Drexel University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Hemoglobin, Sickle, Anemia, Sickle Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The drug voxelotor (commercially known as Oxbryta) has been approved by the US Food and Drug Administration for the treatment of sickle cell disease. It is known to reduce disease-causing sickling by inhibiting the transformation of the non-polymerizing, high-oxygen-affinity R quaternary structure of sickle hemoglobin into its polymerizing, low-affinity T quaternary structure. It has not been established whether the binding of the drug has anti-sickling effects beyond restricting the change of quaternary structure. By using a laser photolysis method that employs microscope optics, we have determined that fully deoxygenated sickle hemoglobin will assume the T structure. We show that the nucleation rates essential to generate the sickle fibers are not significantly affected by voxelotor. The method employed here should be useful for determining the mechanism of sickling inhibition for proposed drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physics, Drexel University, Philadelphia, Pennsylvania.
- Department of Physics, Drexel University, Philadelphia, Pennsylvania. Electronic address: ferronfa@drexel.edu.
Zitieren
APA
Worth, E. H., Fugate, M. K., & Ferrone, F. A. (2023). Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation. Biophysical Journal. https://doi.org/10.1016/j.bpj.2023.05.034
Vancouver
Worth EH, Fugate MK, Ferrone FA. Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation. Biophysical Journal. 2023. doi:10.1016/j.bpj.2023.05.034
BibTeX
@article{Worth2023,
author = {Worth, Eli H and Fugate, Mark K and Ferrone, Frank A},
title = {Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation},
journal = {Biophysical Journal},
year = {2023},
doi = {10.1016/j.bpj.2023.05.034}
}
EUVIMED